Graf Akcie HRTX (Heron Therapeutics Inc). Diskuze k akciím HRTX. Aktuální informace HRTX.

Základní informace o společnosti Heron Therapeutics Inc (Akcie HRTX)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.08B
Hodnota podniku (EV) N/A
Tržby 83.031M
EBITDA N/A
Zisk -234.14
Růst v tržbách Q/Q -0.99 %
Růst v tržbách Y/Y -33.98 %
P/E (Cena vůči ziskům) 0.00
Forward P/E 1.53
EV/Sales 13.28
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 12.95
P/FCF N/A
Price/Book 4.55
Účetní hodnota na akcii 2.35
Hotovost na akcii 2.07
FCF vůči ceně -18.95 %
Počet zaměstnanců 223
Tržba na zaměstnance 372.336k
Profit margin -256.41 %
Operating margin -279.73 %
Gross margin 59.17 %
EBIT margin -284.07 %
EBITDA margin -202.34 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 1.64 %
EPS - Očekávaný růst příští rok -3.13 %
Return on assets -64.20 %
Return on equity -107.65 %
ROIC -52.87 %
ROCE -73.23 %
Dluhy/Equity 0.50
Čistý dluh/EBITDA 5.80
Current ratio 4.47
Quick Ratio 3.94
Volatilita 4.77
Beta 0.91
RSI 42.52
Cílová cena analytiků 31
Známka akcie (dle analytiků) N/A
Insider ownership 0.14 %
Institutional ownership 91.62 %
Počet akcií 101.909M
Procento shortovaných akcií 29.60 %
Short ratio 24.50 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2012
Země United States

Finanční výsledky akcie HRTX

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$88.638$145.968$77.474$30.767$1.279-
Cost Of Goods Sold$36.189$61.619$27.512$4.588$0.035-
Gross Profit$52.449$84.349$49.962$26.179$1.244-
Research And Development Expenses$174.533$167.382$140.032$138.582$103.125$61.183
SG&A Expenses$106.079$127.661$93.867$82.155$69.034$35.742
Other Operating Income Or Expenses------
Operating Expenses$316.801$356.662$261.411$225.325$172.194$96.925
Operating Income$-228.163$-210.694$-183.937$-194.558$-170.915$-96.925
Total Non-Operating Income/Expense$0.885$5.945$5.097$-2.926$-2.228$-0.666
Pre-Tax Income$-227.278$-204.749$-178.84$-197.484$-173.143$-97.591
Income Taxes------
Income After Taxes$-227.278$-204.749$-178.84$-197.484$-173.143$-97.591
Other Income------
Income From Continuous Operations$-227.278$-204.749$-178.84$-197.484$-173.143$-97.591
Income From Discontinued Operations------
Net Income$-227.278$-204.749$-178.84$-197.484$-173.143$-97.591
EBITDA$-223.762$-211.33$-184.946$-192.532$-168.853$-95.478
EBIT$-228.163$-210.694$-183.937$-194.558$-170.915$-96.925
Basic Shares Outstanding918273543833
Shares Outstanding918273543833
Basic EPS$-2.50$-2.50$-2.44$-3.65$-4.56$-2.95
EPS - Earnings Per Share$-2.50$-2.50$-2.44$-3.65$-4.56$-2.95
# 2020 2019 2018 2017 2016 2015
Current Ratio3.06524.95394.86042.21051.60446.828
Long-term Debt / Capital----1.7392-
Debt/Equity Ratio0.02980.01390.01240.2187-2.48980.0188
Gross Margin59.172157.78664.488785.087997.2635-
Operating Margin-257.4099-144.3426-237.4177-632.3593-13363.17-
EBIT Margin-257.4099-144.3426-237.4177-632.3593-13363.17-
EBITDA Margin-252.4448-144.7783-238.7201-625.7744-13201.96-
Pre-Tax Profit Margin-256.4115-140.2698-230.8387-641.8695-13537.37-
Net Profit Margin-256.4115-140.2698-230.8387-641.8695-13537.37-
Asset Turnover0.25070.28470.16760.13130.019-
Inventory Turnover Ratio0.86362.46790.70490.45390.0066-
Receiveable Turnover2.1183.66031.19830.73480.6526-
Days Sales In Receivables172.33399.7194304.5923496.7663559.3432-
ROE - Return On Equity-96.1039-50.7012-48.3142-150.5948814.7518-82.6272
Return On Tangible Equity-96.1039-50.7012-48.3142-150.5948814.7522-82.6272
ROA - Return On Assets-64.2835-39.9291-38.695-84.2843-256.5765-70.7976
ROI - Return On Investment-96.1039-50.7012-48.3142-150.5948-602.2574-82.6272
Book Value Per Share2.594.4724.73512.0297-0.53733.2712
Operating Cash Flow Per Share-0.51261.09710.53090.3844-1.1621-0.1048
Free Cash Flow Per Share-0.50021.13460.45170.4213-1.2192-0.0763

Porovnání s konkurencí: Akcie HRTX

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
HRTX 0.00 N/A -33.98 % -3.13 % -107.65 % 4.55 -256.41 %
Akcie ALKS N/A 2.31 -5.30 % -80.77 % -5.84 % 4.70 -10.67 %
Akcie DRRX N/A N/A -88.00 % 0.00 % -42.18 % 6.81 -1.93 %
Akcie LGND 45.23 1.61 99.11 % -0.96 % 6.52 % 3.01 -1.60 %
Akcie NKTR N/A 0.91 -35.09 % 31.15 % -45.74 % 2.89 -290.65 %
Akcie SRDX 507.18 4.00 0.55 % 38.89 % 1.15 % 5.81 1.18 %

Nedávné obchody insiderů: Akcie HRTX

Jméno Obchod Cena Objem
Barry D Quart
Chief Executive Officer
Nákup
3 Oct 2019
$17.50 $79,993
Kevin C Tang
Director
Nákup
4 Oct 2019
$17.50 $4,999,995
Kimberly Manhard
EVP and Drug Development
Option
29 Nov 2019
$13.00 $312,000
Kimberly Manhard
EVP and Drug Development
Prodej
1 May 2020
$13.97 $16,177
Kimberly Manhard
EVP and Drug Development
Option
22 Dec 2020
$13.00 $130,000
David Leslie Szekeres
EVP and Chief Operating Officer
Prodej
8 Jan 2021
$19.66 $70,206
Kimberly Manhard
EVP and Drug Development
Option
13 Jan 2021
$18.16 $22,700
Lisa Peraza
Vice President and Chief Accounting Officer
Option
13 Jan 2021
$18.16 $10,024
John Poyhonen
President and CCO
Option
13 Jan 2021
$18.16 $22,700
Barry D Quart
Chief Executive Officer
Option
13 Jan 2021
$18.16 $66,211
David Leslie Szekeres
EVP and Chief Operating Officer
Option
13 Jan 2021
$18.16 $22,700

Diskuze k akciím HRTX